Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-301.83%
operating margin TTM
-343.29%
revenue TTM
6.41 Million
revenue per share TTM
1.09$
valuation ratios | |
|---|---|
| pe ratio | -0.96 |
| peg ratio | -0.05 |
| price to book ratio | -2.38 |
| price to sales ratio | 2.17 |
| enterprise value multiple | -0.59 |
| price fair value | -2.38 |
profitability ratios | |
|---|---|
| gross profit margin | 26.42% |
| operating profit margin | -343.29% |
| pretax profit margin | -301.83% |
| net profit margin | -301.83% |
| return on assets | -184.65% |
| return on equity | 271.49% |
| return on capital employed | 285.45% |
liquidity ratio | |
|---|---|
| current ratio | 0.44 |
| quick ratio | 0.44 |
| cash ratio | 0.10 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 0.00 |
| days of payables outstanding | 0.00 |
| cash conversion cycle | 0.00 |
| receivables turnover | 0.00 |
| payables turnover | 0.00 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.49 |
| debt equity ratio | -0.66 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | -1.92 |
| interest coverage | -3.93 |
| cash flow to debt ratio | -3.30 |
cash flow ratios | |
|---|---|
| free cash flow per share | -1.52 |
| cash per share | 0.61 |
| operating cash flow per share | -1.43 |
| free cash flow operating cash flow ratio | 1.06 |
| cash flow coverage ratios | -3.30 |
| short term coverage ratios | -3.34 |
| capital expenditure coverage ratio | -15.55 |
Frequently Asked Questions
When was the last time Plus Therapeutics, Inc. (NASDAQ:PSTV) reported earnings?
Plus Therapeutics, Inc. (PSTV) published its most recent earnings results on 14-11-2024.
What is Plus Therapeutics, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Plus Therapeutics, Inc. (NASDAQ:PSTV)'s trailing twelve months ROE is 271.49%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Plus Therapeutics, Inc. (PSTV) currently has a ROA of -184.65%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did PSTV's net profit margin stand at?
PSTV reported a profit margin of -301.83% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is PSTV's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 0.44 in the most recent quarter. The quick ratio stood at 0.44, with a Debt/Eq ratio of -0.66.